Florida and Texas made a quiet move last week that could have huge implications nationwide: Their attorneys general asked to join a federal lawsuit against the Food and Drug Administration that seeks to drastically roll back access to the main abortion drug, mifepristone. The states argue that the medication's FDA approval should be revoked or, failing that, that telemedicine prescriptions should be once again banned. Telehealth has allowed thousands of people to get abortion pills in states where the procedure is prohibited.
At Bask Health, we once forced every new patient to download a separate app just to upload their ID. Only 40% of them made it through. Six weeks of development, thousands of dollars spent, and we called it a funnel. That one decision cost us more patients than any Facebook ad ever brought in. Turns out, healthcare has a cart abandonment problem, just like ecommerce. But instead of a forgotten pair of sneakers, it's unbooked visits, lost revenue and patients who still need help.